Literature DB >> 19098309

Cysteine string protein promotes proteasomal degradation of the cystic fibrosis transmembrane conductance regulator (CFTR) by increasing its interaction with the C terminus of Hsp70-interacting protein and promoting CFTR ubiquitylation.

Béla Z Schmidt1, Rebecca J Watts, Meir Aridor, Raymond A Frizzell.   

Abstract

Cysteine string protein (Csp) is a J-domain-containing protein whose overexpression blocks the exit of cystic fibrosis transmembrane conductance regulator (CFTR) from the endoplasmic reticulum (ER). Another method of blocking ER exit, the overexpression of Sar1-GTP, however, yielded twice as much immature CFTR compared with Csp overexpression. This finding suggested that Csp not only inhibits CFTR ER exit but also facilitates the degradation of immature CFTR. This was confirmed by treatment with a proteasome inhibitor, which returned the level of immature CFTR to that found in cells expressing Sar1-GTP only. CspH43Q, which does not interact with Hsc70/Hsp70 efficiently, did not promote CFTR degradation, suggesting that the pro-degradative effect of Csp requires Hsc70/Hsp70 binding/activation. In agreement with this, Csp overexpression increased the amount of Hsc70/Hsp70 co-immunoprecipitated with CFTR, whereas overexpression of CspH43Q did not. The Hsc70/Hsp70 binding partner C terminus of Hsp70-interacting protein (CHIP) can target CFTR for proteasome-mediated degradation. Csp overexpression also increased the amount of CHIP co-immunoprecipitated with CFTR. In addition, CHIP interacted directly with Csp, which was confirmed by in vitro binding experiments. Csp overexpression also increased CFTR ubiquitylation and reduced the half-life of immature CFTR. These findings indicate that Csp not only regulates the exit of CFTR from the ER, but that this action is accompanied by Hsc70/Hsp70 and CHIP-mediated CFTR degradation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19098309      PMCID: PMC2640980          DOI: 10.1074/jbc.M806485200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  Hsp70 molecular chaperone facilitates endoplasmic reticulum-associated protein degradation of cystic fibrosis transmembrane conductance regulator in yeast.

Authors:  Y Zhang; G Nijbroek; M L Sullivan; A A McCracken; S C Watkins; S Michaelis; J L Brodsky
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

2.  Cdc48 (p97): a "molecular gearbox" in the ubiquitin pathway?

Authors:  Stefan Jentsch; Sebastian Rumpf
Journal:  Trends Biochem Sci       Date:  2006-12-04       Impact factor: 13.807

3.  Molecular anatomy of a trafficking organelle.

Authors:  Shigeo Takamori; Matthew Holt; Katinka Stenius; Edward A Lemke; Mads Grønborg; Dietmar Riedel; Henning Urlaub; Stephan Schenck; Britta Brügger; Philippe Ringler; Shirley A Müller; Burkhard Rammner; Frauke Gräter; Jochen S Hub; Bert L De Groot; Gottfried Mieskes; Yoshinori Moriyama; Jürgen Klingauf; Helmut Grubmüller; John Heuser; Felix Wieland; Reinhard Jahn
Journal:  Cell       Date:  2006-11-17       Impact factor: 41.582

Review 4.  p97: The cell's molecular purgatory?

Authors:  Dalia Halawani; Martin Latterich
Journal:  Mol Cell       Date:  2006-06-23       Impact factor: 17.970

5.  BAG-2 acts as an inhibitor of the chaperone-associated ubiquitin ligase CHIP.

Authors:  Verena Arndt; Christina Daniel; Wolfgang Nastainczyk; Simon Alberti; Jörg Höhfeld
Journal:  Mol Biol Cell       Date:  2005-10-05       Impact factor: 4.138

6.  p37 is a p97 adaptor required for Golgi and ER biogenesis in interphase and at the end of mitosis.

Authors:  Keiji Uchiyama; Go Totsukawa; Maija Puhka; Yayoi Kaneko; Eija Jokitalo; Ingrid Dreveny; Fabienne Beuron; Xiaodong Zhang; Paul Freemont; Hisao Kondo
Journal:  Dev Cell       Date:  2006-12       Impact factor: 12.270

7.  Episomal expression of wild-type CFTR corrects cAMP-dependent chloride transport in respiratory epithelial cells.

Authors:  D C Lei; K Kunzelmann; T Koslowsky; M J Yezzi; L C Escobar; Z Xu; A R Ellison; J M Rommens; M Tykocinski; D C Gruenert
Journal:  Gene Ther       Date:  1996-05       Impact factor: 5.250

Review 8.  The diversity of the DnaJ/Hsp40 family, the crucial partners for Hsp70 chaperones.

Authors:  X-B Qiu; Y-M Shao; S Miao; L Wang
Journal:  Cell Mol Life Sci       Date:  2006-11       Impact factor: 9.261

9.  Cysteine string proteins are associated with chromaffin granules.

Authors:  L H Chamberlain; J Henry; R D Burgoyne
Journal:  J Biol Chem       Date:  1996-08-09       Impact factor: 5.157

10.  Cysteine string protein monitors late steps in cystic fibrosis transmembrane conductance regulator biogenesis.

Authors:  Hui Zhang; Bela Z Schmidt; Fei Sun; Steven B Condliffe; Michael B Butterworth; Robert T Youker; Jeffrey L Brodsky; Meir Aridor; Raymond A Frizzell
Journal:  J Biol Chem       Date:  2006-02-09       Impact factor: 5.157

View more
  29 in total

1.  E2 conjugating enzyme selectivity and requirements for function of the E3 ubiquitin ligase CHIP.

Authors:  Sarah E Soss; Yuanyuan Yue; Sirano Dhe-Paganon; Walter J Chazin
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

Review 2.  Cystic fibrosis transmembrane conductance regulator degradation: cross-talk between the ubiquitylation and SUMOylation pathways.

Authors:  Annette Ahner; Xiaoyan Gong; Raymond A Frizzell
Journal:  FEBS J       Date:  2013-07-22       Impact factor: 5.542

Review 3.  Trafficking and function of the cystic fibrosis transmembrane conductance regulator: a complex network of posttranslational modifications.

Authors:  Michelle L McClure; Stephen Barnes; Jeffrey L Brodsky; Eric J Sorscher
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-07-29       Impact factor: 5.464

4.  A Proteomic Variant Approach (ProVarA) for Personalized Medicine of Inherited and Somatic Disease.

Authors:  Darren M Hutt; Salvatore Loguercio; Alexandre Rosa Campos; William E Balch
Journal:  J Mol Biol       Date:  2018-06-18       Impact factor: 5.469

5.  Ubiquitination of disease-causing CFTR variants in a microsome-based assay.

Authors:  Samuel K Estabrooks; Jeffrey L Brodsky
Journal:  Anal Biochem       Date:  2020-07-01       Impact factor: 3.365

Review 6.  Applications of proteomic technologies for understanding the premature proteolysis of CFTR.

Authors:  Mark J Henderson; Om V Singh; Pamela L Zeitlin
Journal:  Expert Rev Proteomics       Date:  2010-08       Impact factor: 3.940

Review 7.  Chemical and/or biological therapeutic strategies to ameliorate protein misfolding diseases.

Authors:  Derrick Sek Tong Ong; Jeffery W Kelly
Journal:  Curr Opin Cell Biol       Date:  2010-12-09       Impact factor: 8.382

8.  Correcting the F508del-CFTR variant by modulating eukaryotic translation initiation factor 3-mediated translation initiation.

Authors:  Darren M Hutt; Salvatore Loguercio; Daniela Martino Roth; Andrew I Su; William E Balch
Journal:  J Biol Chem       Date:  2018-07-13       Impact factor: 5.157

Review 9.  Hallmarks of therapeutic management of the cystic fibrosis functional landscape.

Authors:  Margarida D Amaral; William E Balch
Journal:  J Cyst Fibros       Date:  2015-10-29       Impact factor: 5.482

10.  SnAvi--a new tandem tag for high-affinity protein-complex purification.

Authors:  Ursula Schäffer; Andreas Schlosser; Kristian M Müller; Angelika Schäfer; Nenad Katava; Ralf Baumeister; Ekkehard Schulze
Journal:  Nucleic Acids Res       Date:  2010-01-04       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.